Announcement

Mark Tullis

Mark is Co-founder/Editor of TechBuzz News. From Ogden, UT, Mark attended WSU, BYU, and Tufts. He has been involved in tech, media, publishing since the 80s.

Location Lehi, UT
Number of Articles 2518
Socials
Mark Tullis's Work 2518 Articles
Money   -   Dec 28, 2020 Qualtrics Files IPO Papers—Company Set to Raise $14+ Billion in Early 2021
Qualtrics Files IPO Papers—Company Set to Raise $14+ Billion in Early 2021

Nearing the end of an already record-breaking year for Utah’s technology sector, yesterday Qualtrics filed its S-1 with the Securities and Exchange Commission (SEC), which would set the company's valuation on a fully diluted basis of between $12 billion and $14.4 billion—yet another

by Mark Tullis
Money   -   Dec 21, 2020 Jane Raises a $40 Million Series A Investment
Jane Raises a $40 Million Series A Investment

Today, Jane, an online marketplace based in Lehi, announced it has raised $40 million in a Series A investment from Austin-based Tritium Partners. Jane is a boutique marketplace where customers, mostly women, can find high quality products—clothing, accessories, shoes and home decor—from a curated network of over

by Mark Tullis
Money   -   Dec 21, 2020 Jane Raises a $40 Million Series A Investment
Jane Raises a $40 Million Series A Investment

Today, Jane, an online marketplace based in Lehi, announced it has raised $40 million in a Series A investment from Austin-based Tritium Partners. Jane is a boutique marketplace where customers, mostly women, can find high quality products—clothing, accessories, shoes and home decor—from a curated network of over

by Mark Tullis
Money   -   Dec 20, 2020 PathologyWatch Raises a $7 Million Series A Investment
PathologyWatch Raises a $7 Million Series A Investment

PathologyWatch has announced $2 million in extension funding of its $5 million series A round that it raised earlier this year. The extension funding comes from life science investors based in Germany, Neue Fund, and Bioventures GmbH. Lateral Capital, BeniVC, and Sky Ventures also participated in the extension round.   In

by Mark Tullis
Money   -   Dec 20, 2020 PathologyWatch Raises a $7 Million Series A Investment
PathologyWatch Raises a $7 Million Series A Investment

PathologyWatch has announced $2 million in extension funding of its $5 million series A round that it raised earlier this year. The extension funding comes from life science investors based in Germany, Neue Fund, and Bioventures GmbH. Lateral Capital, BeniVC, and Sky Ventures also participated in the extension round.   In

by Mark Tullis
Money   -   Dec 12, 2020 Pluralsight to be Acquired by Vista Equity Partners for $3.5 Billion
Pluralsight to be Acquired by Vista Equity Partners for $3.5 Billion

Vista Equity Partners (“Vista”) today announced that it has agreed to acquire Pluralsight, Inc., the technology workforce development company for $3.5 billion. It is an all-cash transaction acquiring all outstanding shares of Pluralsight common stock for $20.26 per share. The company’s stock dropped precipitously in March

by Mark Tullis
Money   -   Dec 12, 2020 Pluralsight to be Acquired by Vista Equity Partners for $3.5 Billion
Pluralsight to be Acquired by Vista Equity Partners for $3.5 Billion

Vista Equity Partners (“Vista”) today announced that it has agreed to acquire Pluralsight, Inc., the technology workforce development company for $3.5 billion. It is an all-cash transaction acquiring all outstanding shares of Pluralsight common stock for $20.26 per share. The company’s stock dropped precipitously in March

by Mark Tullis
Money   -   Dec 10, 2020 Thoma Bravo Announces Strategic Investment In Venafi, Values Company at $1.15 Billion
Thoma Bravo Announces Strategic Investment In Venafi, Values Company at $1.15 Billion

Thoma Bravo, a private equity investment firm with offices in Chicago and San Francisco, announced a strategic growth investment in Venafi, the Salt Lake City-based cybersecurity pioneer and inventor of machine identity protection. The transaction values Venafi at $1.15 billion and continues Thoma Bravo’s tradition of acquiring

by Mark Tullis
Your link has expired. Please request a new one.
Your link has expired. Please request a new one.
Your link has expired. Please request a new one.
Great! You've successfully signed up.
Great! You've successfully signed up.
Welcome back! You've successfully signed in.
Success! You now have access to additional content.